Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMC 2820609)

Published in BMJ on February 11, 2010

Authors

Marina T van Leeuwen1, Angela C Webster, Margaret R E McCredie, John H Stewart, Stephen P McDonald, Janaki Amin, John M Kaldor, Jeremy R Chapman, Claire M Vajdic, Andrew E Grulich

Author Affiliations

1: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 376 Victoria St, Sydney, NSW, 2010, Australia.

Articles citing this

Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer (2012) 1.41

The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas. J Cancer (2013) 1.30

Cancer in the transplant recipient. Cold Spring Harb Perspect Med (2013) 1.06

Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo. PLoS One (2010) 0.98

De novo malignancy post-liver transplantation: a single center, population controlled study. Clin Transplant (2013) 0.91

Melanoma Risk and Survival among Organ Transplant Recipients. J Invest Dermatol (2015) 0.85

Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction Intervals. J Am Soc Nephrol (2015) 0.81

Early diagnosis and treatment of breast cancer in Japanese kidney transplant recipients: a single center experience. Springerplus (2015) 0.80

Lung Cancer Prognosis in Elderly Solid Organ Transplant Recipients. Transplantation (2015) 0.79

Facial and hand allotransplantation. Cold Spring Harb Perspect Med (2014) 0.78

Risk of human papillomavirus-related cancers among kidney transplant recipients and patients receiving chronic dialysis--an observational cohort study. BMC Nephrol (2013) 0.77

Transplantation-induced cancers: Emerging evidence that clonal CMV-specific NK cells are causal immunogenic factors. Oncoimmunology (2014) 0.76

Effects of opioids on immunologic parameters that are relevant to anti-tumour immune potential in patients with cancer: a systematic literature review. Br J Cancer (2014) 0.76

Management of patients with a failed kidney transplant: Dialysis reinitiation, immunosuppression weaning, and transplantectomy. World J Nephrol (2015) 0.75

Viruses in case series of tumors: Consistent presence in different cancers in the same subject. PLoS One (2017) 0.75

Chemotherapy for urothelial carcinoma in renal transplantation patients: Initial results from a single center. Mol Clin Oncol (2015) 0.75

Clinical and Economic Consequences of Early Cancer after Kidney Transplantation in Contemporary Practice. Transplantation (2016) 0.75

The benefits of cancer screening in kidney transplant recipients: a single-center experience. Cancer Med (2015) 0.75

Urothelial carcinoma of donor origin in a kidney transplant patient. J Immunother Cancer (2016) 0.75

Malignancies in a renal transplant population: The St. Michael's Hospital experience. Urol Ann (2016) 0.75

De novo cancer in patients on dialysis and after renal transplantation: north-western Italy, 1997-2012. J Nephrol (2017) 0.75

Risk of thyroid cancer among solid organ transplant recipients. Am J Transplant (2017) 0.75

Articles cited by this

THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION? Proc R Soc Med (1965) 40.52

Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ (1987) 27.11

A review of human carcinogens--Part B: biological agents. Lancet Oncol (2009) 13.85

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06

Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med (2008) 7.71

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst (2005) 6.69

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med (1989) 6.66

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77

The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol (2007) 2.19

Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer (2008) 1.70

ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry. Am J Kidney Dis (2002) 1.69

Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS (2008) 1.60

Cancer in end-stage renal disease: potential factors involved -editorial-. Am J Nephrol (1998) 1.28

Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood (2009) 1.23

Clinical and dermatoscopic fading of post-transplant eruptive melanocytic nevi after suspension of immunosuppressive therapy. J Am Acad Dermatol (2006) 1.22

Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma. Transplantation (2008) 1.06

Cutaneous melanoma is related to immune suppression in kidney transplant recipients. Cancer Epidemiol Biomarkers Prev (2009) 1.05

Depressed immunity and the development of cancer. Cancer Detect Prev (1994) 1.04

Kaposi sarcoma in transplantation. Transplant Rev (Orlando) (2008) 1.00

The role of immunosuppression in lymphoma formation. Springer Semin Immunopathol (1998) 0.99

Patient outcomes after kidney allograft loss. Transplant Rev (Orlando) (2008) 0.92

Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiol Biomarkers Prev (2009) 0.92

Prediagnostic serum selenium in a case-control study of thyroid cancer. Int J Epidemiol (1989) 0.91

Secondary hyperparathyroidism: evidence for an association with papillary thyroid cancer. Am Surg (2001) 0.81

Articles by these authors

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06

The natural history of chronic allograft nephropathy. N Engl J Med (2003) 8.70

A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet (2007) 7.35

Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med (2002) 6.19

Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol (2012) 6.05

Relation between HIV viral load and infectiousness: a model-based analysis. Lancet (2008) 5.74

Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis (2010) 5.39

Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77

Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet (2006) 4.45

Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ (2013) 4.08

Mass Drug Administration for Scabies Control in a Population with Endemic Disease. N Engl J Med (2015) 4.06

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood (2008) 3.81

Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men. AIDS (2009) 3.61

Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst (2002) 3.46

Acute rejection, T-cell-depleting antibodies, and cancer after transplantation. Transplantation (2014) 3.40

Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial. Clin Infect Dis (2009) 3.32

Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS (2013) 3.30

The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology (2013) 3.14

How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ (2008) 3.00

Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst (2003) 2.84

HIV prevention research in a resource-limited setting: the experience of planning a trial in Cambodia. Lancet (2005) 2.83

Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol (2006) 2.82

KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int (2009) 2.72

Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. J Virol (2006) 2.70

Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry. J Clin Oncol (2005) 2.70

Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS (2003) 2.69

Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol (2004) 2.66

Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS (2010) 2.65

Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol (2008) 2.59

Male circumcision to reduce the risk of HIV and sexually transmitted infections among men who have sex with men. Curr Opin Infect Dis (2010) 2.57

Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection. Hepatology (2010) 2.56

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55

Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis (2012) 2.51

Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review. Lancet Infect Dis (2009) 2.43

Early acquisition of anogenital human papillomavirus among teenage men who have sex with men. J Infect Dis (2013) 2.40

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37

A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosomes Cancer (2006) 2.35

Screening and follow-up of living kidney donors: a systematic review of clinical practice guidelines. Transplantation (2011) 2.34

"Serosorting" in casual anal sex of HIV-negative gay men is noteworthy and is increasing in Sydney, Australia. AIDS (2006) 2.26

InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood (2010) 2.21

Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev (2014) 2.17

Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.14

Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2007) 2.11

Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet (2005) 2.09

Proton pump inhibitors and acute interstitial nephritis. Clin Gastroenterol Hepatol (2006) 2.07

Effective treatment of injecting drug users with recently acquired hepatitis C virus infection. Gastroenterology (2009) 1.99

Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS (2002) 1.98

Dialysis modality preference of patients with CKD and family caregivers: a discrete-choice study. Am J Kidney Dis (2012) 1.97

Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation. Kidney Int (2009) 1.96

Comparison of cancer mortality and incidence in New Zealand and Australia. N Z Med J (2002) 1.94

Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol (2008) 1.91

Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ (2005) 1.90

Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int (2010) 1.89

Reduction in cardiovascular death after kidney transplantation. Transplantation (2010) 1.89

Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial. JAMA (2002) 1.88

Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction (2006) 1.87

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85

Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence? AIDS (2004) 1.85

Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg (2007) 1.85

Sex in Australia: the rationale and methods of the Australian Study of Health and Relationships. Aust N Z J Public Health (2003) 1.84

Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol (2003) 1.84

Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis (2006) 1.83

Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation (2004) 1.82

Chronic allograft nephropathy: current concepts and future directions. Transplantation (2006) 1.79

The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users. Int J Epidemiol (2003) 1.78

The motivations and experiences of living kidney donors: a thematic synthesis. Am J Kidney Dis (2012) 1.78

Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection. Hepatology (2013) 1.77

Surveillance for newly acquired hepatitis C in Australia. J Gastroenterol Hepatol (2004) 1.77

Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial. Lancet (2014) 1.73

Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency? Blood (2010) 1.71

Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population. Am J Kidney Dis (2011) 1.71

Cohort profile: the TREAT Asia pediatric HIV observational database. Int J Epidemiol (2010) 1.70

Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am J Kidney Dis (2008) 1.69

Circumcision in Australia: prevalence and effects on sexual health. Int J STD AIDS (2006) 1.68

Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Nephrol Dial Transplant (2009) 1.68

High hepatitis C incidence in new injecting drug users: a policy failure? Aust N Z J Public Health (2007) 1.67

Home haemodialysis in Australia - is the wheel turning full circle? Med J Aust (2010) 1.67

Comprehensive clinical care for men who have sex with men: an integrated approach. Lancet (2012) 1.65

Serosorting may increase the risk of HIV acquisition among men who have sex with men. Sex Transm Dis (2010) 1.64

Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation (2006) 1.63

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study. AIDS (2004) 1.61

Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study. Lancet Infect Dis (2015) 1.61

Peritoneal small solute clearance is nonlinearly related to patient survival in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int (2009) 1.61

Estimation of risk of cancers before occurrence of acquired immunodeficiency syndrome in persons infected with human immunodeficiency virus. Am J Epidemiol (2002) 1.60

Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with peritoneal dialysis. Perit Dial Int (2007) 1.59